Mylan barred by UK on Tecfidera appeal
Executive Summary
Mylan has failed to persuade UK Administrative Court Justice Michael Supperstone to refer a dispute over its attempts to file for generic Tecfidera (dimethyl fumarate) to the Court of Justice of the European Union (CJEU).
You may also be interested in...
Three EU Tecfidera Generics Recommended As Biogen Battles For Exclusivity
Following a years-long back-and-forth to establish exclusivity protection for its Tecfidera multiple-sclerosis treatment in Europe, Biogen has ultimately seen the CHMP recommend three generic versions to receive pan-European marketing authorization.
What’s Next? Five Things To Look Out For In October
Generics Bulletin previews the most notable and anticipated events for October 2023.
Pink Sheet Podcast: Adcomm Rejects NurOwn For ALS, FDA In Shutdown Mode, Limited Price Negotiation Savings
Pink Sheet reporters and editors consider the fallout from Brainstorm Cell Therapeutics Inc.’s negative US FDA advisory committee decision on its ALS drug, the impact of a government shutdown on the agency, and a study showing only a limited possibility for significant savings in the first round of Medicare price negotiations.